Spain In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Spain In Vitro Diagnostics Market Outlook to 2018- Clinical
Chemistry Genetic Testing, Haematology, Histology and
Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture
Report Details:
Published:November 2012
No. of Pages: 263
Price: Single User License – US$2500

Spain In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing,
Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture

Summary

GlobalData’s new report, “Spain In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry
Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious
Immunology and Microbiology Culture” provides key market data on the Spain In Vitro Diagnostics
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within market categories – Immuno Chemistry, Clinical
Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology
and Genetic Testing. The report also provides company shares and distribution shares data for
each of the aforementioned market categories. The report is supplemented with global corporate-
level profiles of the key market participants with information on company financials and pipeline
products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories – Immuno
Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture,
Histology And Cytology and Genetic Testing.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for

each of the segments and sub-segments within market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the Spain In Vitro Diagnostics
market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott
Laboratories, Beckman Coulter, Inc., bioMerieux S.A., Ortho-Clinical Diagnostics Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Spain In Vitro Diagnostics
competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.

Get your copy of this report @
http://www.reportsnreports.com/reports/210646-spain-in-vitro-diagnostics-market-outlook-to-2018-clinical-
chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-and-
microbiology-culture.html

Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 17
2.1 What is This Report About? 17
3 In Vitro Diagnostics In Spain 18
3.1 In Vitro Diagnostics, Market Segmentation 18
3.2 In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, 2004-2018 19
3.3 In Vitro Diagnostics Market, Spain, Revenue Mix ($m), 2011 21
3.4 In Vitro Diagnostics Market, Spain, Category Contribution (%), 2011 22
3.5 In Vitro Diagnostics, Spain, Company Share (2010-2011) 29
4 Clinical Chemistry In Spain 31
4.1 Clinical Chemistry, Market Segmentation 31
4.2 Clinical Chemistry Market, Spain, Revenue Mix ($m), 2011 32
4.3 Clinical Chemistry Market, Spain, Segment Contribution (%), 2011 33
4.4 Clinical Chemistry Overall Revenue, (2004-2018) 34
4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 38

4.4.2 Urine Analysis, Revenue (2004-2018) 42
4.5 Clinical Chemistry Distribution Share (2010-2011) 46
4.6 Clinical Chemistry, Spain, Company Share (2010-2011) 47
5 Genetic Testing In Spain 49
5.1 Genetic Testing, Market Segmentation 49
5.2 Genetic Testing Market, Spain, Revenue Mix ($m), 2011 50
5.3 Genetic Testing Market, Spain, Segment Contribution (%), 2011 51
5.4 Genetic Testing Overall Revenue, (2004-2018) 52
5.5 Genetic Testing Distribution Share (2010-2011) 56
5.6 Genetic Testing, Spain, Company Share (2010-2011) 57
6 Haematology In Spain 58
6.1 Haematology Market, Market Segmentation 58
6.2 Haematology Market, Spain, Revenue Mix ($m), 2011 59
6.3 Haematology Market, Spain, Segment Contribution (%), 2011 60
6.4 Haematology Overall Revenue, (2004-2018) 61
6.4.1 Haematology Reagents, Revenue (2004-2018) 65
6.4.2 Immunohaematology, Revenue (2004-2018) 69
6.4.3 Haemostasis, Revenue (2004-2018) 73
6.4.4 Haematology Rapid Tests, Revenue (2004-2018) 77
6.4.5 Haematology Cell Counters, Revenue (2004-2018) 81
6.5 Haematology Distribution Share (2010-2011) 85
6.6 Haematology, Spain, Company Share (2010-2011) 86
7 Histology And Cytology In Spain 88
7.1 Histology and Cytology Market, Market Segmentation 88
7.2 Histology And Cytology Market, Spain, Revenue Mix ($m), 2011 89
7.3 Histology And Cytology Market, Spain, Segment Contribution (%), 2011 90
7.4 Histology And Cytology Overall Revenue, (2004-2018) 91
7.5 Histology And Cytology Distribution Share (2010-2011) 95
7.6 Histology And Cytology, Spain, Company Share (2010-2011) 96
8 Immuno Chemistry In Spain 98
8.1 Immuno Chemistry Market, Spain, Revenue Mix ($m), 2011 98
8.2 Immuno Chemistry Market, Spain, Segment Contribution (%), 2011 99
8.3 Immuno Chemistry Overall Revenue, (2004-2018) 100
8.3.1 Disease Specific Immunochemistry, Revenue (2004-2018) 104
8.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 108
8.3.3 Endocrinology Tests, Revenue (2004-2018) 112
8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 116
8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 120
8.3.6 Immunochemistry Analyzers, Revenue (2004-2018) 124
8.4 Immuno Chemistry Distribution Share (2010-2011) 128
8.5 Immuno Chemistry, Spain, Company Share (2010-2011) 129
9 Infectious Immunology In Spain 131

9.1 Infectious Immunology, Market Segmentation 131
9.2 Infectious Immunology Market, Spain, Revenue Mix ($m), 2011 132
9.3 Infectious Immunology Market, Spain, Segment Contribution (%), 2011 133
9.4 Infectious Immunology Overall Revenue, (2004-2018) 134
9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 138
9.5 Infectious Immunology Distribution Share (2010-2011) 142
9.6 Infectious Immunology, Spain, Company Share (2010-2011) 143
10 Microbiology Culture In Spain 145
10.1 Microbiology Culture, Market Segmentation 145
10.2 Microbiology Culture Market, Spain, Revenue Mix ($m), 2011 146
10.3 Microbiology Culture Market, Spain, Segment Contribution (%), 2011 147
10.4 Microbiology Culture Overall Revenue, (2004-2018) 148
10.4.1 Microbiology Analyzers, Revenue (2004-2018) 152
10.5 Microbiology Culture Distribution Share (2010-2011) 156
10.6 Microbiology Culture, Spain, Company Share (2010-2011) 157
11 Overview of Key Companies in Spain In Vitro Diagnostics Market 159
11.1 Siemens Healthcare 159
11.1.1 Company Overview 159
11.1.2 Share in the Spain In Vitro Diagnostics Market 159
11.2 F. Hoffmann-La Roche Ltd. 160
11.3 Abbott Laboratories 161
11.4 Beckman Coulter, Inc. 162
11.5 bioMerieux S.A. 163
11.6 Ortho-Clinical Diagnostics Inc. 164
11.7 Bio-Rad Laboratories, Inc. 165
11.8 Sysmex Corporation 165
11.9 Becton, Dickinson and Company 166
11.10 Alere Inc. 166

11.11 Qiagen N.V. 167
11.12 Horiba, Ltd. 167
11.13 Diagnostica Stago, Inc. 168
11.14 DiaSorin S.p.A 168
11.15 Olympus Corporation 169
11.16 PerkinElmer, Inc. 169
11.17 Gen-Probe Incorporated 170
11.18 Thermo Fisher Scientific Inc. 170
11.19 Grifols, S.A. 171
11.20 Immucor, Inc. 171
11.21 Mindray Medical International Limited 172
11.22 Cellestis Limited 172
11.23 Hologic, Inc. 173
11.24 Life Technologies Corporation 173
12 In Vitro Diagnostics Market Pipeline Products 174
12.1 Clinical Chemisty Market Pipeline Products 174
12.2 Immuno Chemistry Market Pipeline Products 177
12.3 Haematology Market Pipeline Products 186
12.4 Infectious Immunology Market Pipeline Products 188
12.5 Microbiology Culture Market Pipeline Products 195
12.6 Histology And Cytology Market Pipeline Products 196
12.7 Genetic Testing Market Pipeline Products 197
13 Financial Deals Landscape 202
13.1 Partnerships 202
13.1.1 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 202
13.1.2 Scienion Enters Into Co-Development Agreement With Genomica 204
13.1.3 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For
Archimedes Particle Metrology System 205

13.1.4 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 206
13.1.5 BioDot Enters Into Co-Marketing Agreement With JOT Automation 207
13.1.6 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology
Assays 208
13.1.7 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital
Microscopy Hematology Solutions 209
13.1.8 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress
Dx Test 211
13.1.9 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
213
13.1.10 Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 214
13.1.11 CML HealthCare Enters Into Agreement With MaRS Innovation 215
13.1.12 Akrivis Technologies Enters Into Co-Development Agreement With United States
Biological 216
13.1.13 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women''s Hospital
For Mesothelioma Test 217
13.1.14 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein
Array Products 218
13.1.15 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North
Carolina 219
13.1.16 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB
Test 220
13.1.17 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For
PhenoFluor 221
13.1.18 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 222
13.1.19 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 223
13.1.20 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
224
13.1.21 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 225
13.1.22 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC
Test 226
13.1.23 One Lambda Enters Into Co-Marketing Agreement With CellTrend 227
13.1.24 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For
ALK Cancer Biomarker 228
13.1.25 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 229
13.1.26 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
230
13.1.27 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell
Technology 231
13.1.28 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 232
13.1.29 Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker
Analysis Platforms 233

13.1.30 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange
PCR Kit 234
13.1.31 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 235
13.1.32 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For
Pressure Cycling Technology 236
13.1.33 LipoScience Enters Into Licensing Agreement With Cleveland Clinic 237
13.1.34 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact
Cyclotron And PET Tracer System 238
13.1.35 Sysmex Extends Distribution Agreement With Roche 239
13.1.36 NexDx Enters Into Licensing Agreement With University of California For Epigenetic
Biomarkers 240
13.1.37 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 241
13.1.38 Saladax Biomedical Enters Into Co-Marketing Agreement With INyDIA Laboratorios
Biomedical Diagnostics For My5-FU 242
13.1.39 Hamilton Thorne Expands Co-Marketing Agreement With Leica Microsystems 243
13.1.40 Integromics Enters Into Co-Development Agreement With Galician Foundation Of
Genomic Medicine 244
13.1.41 Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay
For Sepsis 245
14 Recent Developments 246
14.1 Strategy And Business Planning 246
14.1.1 May 07, 2012: Werfen Decides To End Beckman Coulter Hemostasis Alliance 246
14.1.2 Mar 03, 2012: Biokilab Inaugurates New Facilities At Álava Technology Park 246
14.2 Government and Public Interest 246
14.2.1 Apr 06, 2012: Systelab And Other IICC Founding Members To Participate At Connectathon
2012 In Bern, Switzerland 246
14.2.2 Mar 26, 2012: Systelab To Give Presentation Titled ‘Modulab LIS as a tool for effective
laboratory testing and management’ At 11th Baltic Congress Of Laboratory Medicine, Vilnius 247
14.3 Product News 247
14.3.1 May 25, 2011: USP Hospitales Of Spain To Offer Interleukin'' Heart Health Test Throughout
Its Hospital Network 247
15 Appendix 248
15.1 Definitions of Markets Covered in the Report 249
15.1.1 In Vitro Diagnostics 249
15.2 Research Methodology 260
15.3 Secondary Research 260
15.4 Primary Research 261
15.5 Models 261
15.6 Forecasts 262
15.7 Expert Panels 262
15.8 GlobalData Consulting 262
15.9 Currency Conversion 263

15.10 Contact Us 263
15.11 Disclaimer 263

1.1 List of Tables
Table 1: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, 2004-2018 20
Table 2: In Vitro Diagnostics Market, Spain, Category Contribution (%), 2011 22
Table 3: In Vitro Diagnostics Market, Spain, Cross-Category Analysis, 2004-2018 24
Table 4: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 26
Table 5: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
28
Table 6: In Vitro Diagnostics, Spain, Company Share by Revenue ($m), USD Constant, 2010-
2011 30
Table 7: Clinical Chemistry Market, Spain, Segment Contribution (%), 2011 33
Table 8: Clinical Chemistry, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 35
Table 9: Clinical Chemistry, Spain, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 37
Table 10: Clinical Chemisty Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 39
Table 11: Clinical Chemisty Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 41
Table 12: Urine Analysis, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 43
Table 13: Urine Analysis, Spain, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 45
Table 14: Clinical Chemistry, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 46
Table 15: Clinical Chemistry, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
48
Table 16: Genetic Testing Market, Spain, Segment Contribution (%), 2011 51
Table 17: Genetic Testing, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
53
Table 18: Genetic Testing, Spain, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 55
Table 19: Genetic Testing, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011
56
Table 20: Genetic Testing, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011
57
Table 21: Haematology Market, Spain, Segment Contribution (%), 2011 60
Table 22: Haematology, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 62
Table 23: Haematology, Spain, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
64

Table 24: Haematology Reagents, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 66
Table 25: Haematology Reagents, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 68
Table 26: Immunohaematology, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 70
Table 27: Immunohaematology, Spain, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 72
Table 28: Haemostasis, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 74
Table 29: Haemostasis, Spain, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 76
Table 30: Haematology Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 78
Table 31: Haematology Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 80
Table 32: Haematology Cell Counters, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 82
Table 33: Haematology Cell Counters, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 84
Table 34: Haematology, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 85
Table 35: Haematology, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 87
Table 36: Histology And Cytology Market, Spain, Segment Contribution (%), 2011 90
Table 37: Histology And Cytology, Spain, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 92
Table 38: Histology And Cytology, Spain, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 94
Table 39: Histology And Cytology, Spain, Distribution Share by Revenue ($m), USD Constant,
2010-2011 95
Table 40: Histology And Cytology, Spain, Company Share by Revenue ($m), USD Constant,
2010-2011 97
Table 41: Immuno Chemistry Market, Spain, Segment Contribution (%), 2011 99
Table 42: Immuno Chemistry, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 101
Table 43: Immuno Chemistry, Spain, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 103
Table 44: Disease Specific Immunochemistry, Spain, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 105
Table 45: Disease Specific Immunochemistry, Spain, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 107
Table 46: Drugs of Abuse / Toxicology, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 109

Table 47: Drugs of Abuse / Toxicology, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 111
Table 48: Endocrinology Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 113
Table 49: Endocrinology Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 115
Table 50: Immunochemistry Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 117
Table 51: Immunochemistry Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 119
Table 52: Therapeutic Drug Monitoring, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 121
Table 53: Therapeutic Drug Monitoring, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 123
Table 54: Immunochemistry Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 125
Table 55: Immunochemistry Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 127
Table 56: Immuno Chemistry, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 128
Table 57: Immuno Chemistry, Spain, Company Share by Revenue ($m), USD Constant, 2010-
2011 130
Table 58: Infectious Immunology Market, Spain, Segment Contribution (%), 2011 133
Table 59: Infectious Immunology, Spain, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 135
Table 60: Infectious Immunology, Spain, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 137
Table 61: Infectious Immunology Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-
Table 62: Infectious Immunology Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-
Table 63: Infectious Immunology, Spain, Distribution Share by Revenue ($m), USD Constant,
2010-2011 142
Table 64: Infectious Immunology, Spain, Company Share by Revenue ($m), USD Constant, 2010-
2011 144
Table 65: Microbiology Culture Market, Spain, Segment Contribution (%), 2011 147
Table 66: Microbiology Culture, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 149
Table 67: Microbiology Culture, Spain, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 151
Table 68: Microbiology Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 153

Table 69: Microbiology Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 155
Table 70: Microbiology Culture, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 156
Table 71: Microbiology Culture, Spain, Company Share by Revenue ($m), USD Constant, 2010-
2011 158
Table 72: Clinical Chemisty Market Pipeline Products 174
Table 73: Immuno Chemistry Market Pipeline Products 177
Table 74: Haematology Market Pipeline Products 186
Table 75: Infectious Immunology Market Pipeline Products 188
Table 76: Microbiology Culture Market Pipeline Products 195
Table 77: Histology And Cytology Market Pipeline Products 196
Table 78: Genetic Testing Market Pipeline Products 197
Table 79: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 202
Table 80: Scienion Enters Into Co-Development Agreement With Genomica 204
Table 81: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For
Archimedes Particle Metrology System 205
Table 82: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 206
Table 83: BioDot Enters Into Co-Marketing Agreement With JOT Automation 207
Table 84: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology
Assays 208
Table 85: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital
Microscopy Hematology Solutions 209
Table 86: Med BioGene Amends Licensing Agreement With Precision Therapeutics For
LungExpress Dx Test 211
Table 87: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon
Biotechnology 213
Table 88: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 214
Table 89: CML HealthCare Enters Into Agreement With MaRS Innovation 215
Table 90: Akrivis Technologies Enters Into Co-Development Agreement With United States
Biological 216
Table 91: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women''s
Hospital For Mesothelioma Test 217
Table 92: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein
Array Products 218
Table 93: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North
Carolina 219
Table 94: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium
TB Test 220
Table 95: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For
PhenoFluor 221
Table 96: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 222

Table 97: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
223
Table 98: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
224
Table 99: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 225
Table 100: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4
POC Test 226
Table 101: One Lambda Enters Into Co-Marketing Agreement With CellTrend 227
Table 102: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics
For ALK Cancer Biomarker 228
Table 103: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 229
Table 104: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG
Marker 230
Table 105: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor
Cell Technology 231
Table 106: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 232
Table 107: Isogen Life Science Enters Into Co-Marketing Agreement With Axela For Biomarker
Analysis Platforms 233
Table 108: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For
LongRange PCR Kit 234
Table 109: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 235
Table 110: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For
Pressure Cycling Technology 236
Table 111: LipoScience Enters Into Licensing Agreement With Cleveland Clinic 237
Table 112: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact
Cyclotron And PET Tracer System 238
Table 113: Sysmex Extends Distribution Agreement With Roche 239
Table 114: NexDx Enters Into Licensing Agreement With University of California For Epigenetic
Biomarkers 240
Table 115: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 241
Table 116: Saladax Biomedical Enters Into Co-Marketing Agreement With INyDIA Laboratorios
Biomedical Diagnostics For My5-FU 242
Table 117: Hamilton Thorne Expands Co-Marketing Agreement With Leica Microsystems 243
Table 118: Integromics Enters Into Co-Development Agreement With Galician Foundation Of
Genomic Medicine 244
Table 119: Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT
Assay For Sepsis 245

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 18
Figure 2: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, 2004-2018 19
Figure 3: In Vitro Diagnostics Market, Spain, Revenue Mix ($m), 2011 21

Figure 4: In Vitro Diagnostics Market, Spain, Category Contribution (%), 2011 22
Figure 5: In Vitro Diagnostics Market, Spain, Cross-Category Analysis, 2004-2018 23
Figure 6: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011
25
Figure 7: In Vitro Diagnostics, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
27
Figure 8: In Vitro Diagnostics, Spain, Company Share (%), 2011 29
Figure 9: Clinical Chemistry, Market Segmentation 31
Figure 10: Clinical Chemistry Market, Spain, Revenue Mix ($m), 2011 32
Figure 11: Clinical Chemistry Market, Spain, Segment Contribution (%), 2011 33
Figure 12: Clinical Chemistry, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 34
Figure 13: Clinical Chemistry, Spain, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 36
Figure 14: Clinical Chemisty Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 38
Figure 15: Clinical Chemisty Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 40
Figure 16: Urine Analysis, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 42
Figure 17: Urine Analysis, Spain, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 44
Figure 18: Clinical Chemistry, Spain, Company Share (%), 2011 47
Figure 19: Genetic Testing, Market Segmentation 49
Figure 20: Genetic Testing Market, Spain, Revenue Mix ($m), 2011 50
Figure 21: Genetic Testing Market, Spain, Segment Contribution (%), 2011 51
Figure 22: Genetic Testing, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
52
Figure 23: Genetic Testing, Spain, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 54
Figure 24: Genetic Testing, Spain, Company Share (%), 2011 57
Figure 25: Haematology Market, Market Segmentation 58
Figure 26: Haematology Market, Spain, Revenue Mix ($m), 2011 59
Figure 27: Haematology Market, Spain, Segment Contribution (%), 2011 60
Figure 28: Haematology, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
61
Figure 29: Haematology, Spain, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
63
Figure 30: Haematology Reagents, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 65
Figure 31: Haematology Reagents, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 67

Figure 32: Immunohaematology, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 69
Figure 33: Immunohaematology, Spain, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 71
Figure 34: Haemostasis, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 73
Figure 35: Haemostasis, Spain, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
2018 75
Figure 36: Haematology Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 77
Figure 37: Haematology Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 79
Figure 38: Haematology Cell Counters, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 81
Figure 39: Haematology Cell Counters, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 83
Figure 40: Haematology, Spain, Company Share (%), 2011 86
Figure 41: Histology and Cytology Market, Market Segmentation 88
Figure 42: Histology And Cytology Market, Spain, Revenue Mix ($m), 2011 89
Figure 43: Histology And Cytology Market, Spain, Segment Contribution (%), 2011 90
Figure 44: Histology And Cytology, Spain, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 91
Figure 45: Histology And Cytology, Spain, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 93
Figure 46: Histology And Cytology, Spain, Company Share (%), 2011 96
Figure 47: Immuno Chemistry Market, Spain, Revenue Mix ($m), 2011 98
Figure 48: Immuno Chemistry Market, Spain, Segment Contribution (%), 2011 99
Figure 49: Immuno Chemistry, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 100
Figure 50: Immuno Chemistry, Spain, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 102
Figure 51: Disease Specific Immunochemistry, Spain, Revenue ($m) USD Constant, by Sub-
Figure 52: Disease Specific Immunochemistry, Spain, Revenue ($m) USD Constant, by Sub-
Figure 53: Drugs of Abuse / Toxicology, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 108
Figure 54: Drugs of Abuse / Toxicology, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 110
Figure 55: Endocrinology Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 112
Figure 56: Endocrinology Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment, Forecast,

2011-2018 114
Figure 57: Immunochemistry Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 116
Figure 58: Immunochemistry Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 118
Figure 59: Therapeutic Drug Monitoring, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 120
Figure 60: Therapeutic Drug Monitoring, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 122
Figure 61: Immunochemistry Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 124
Figure 62: Immunochemistry Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 126
Figure 63: Immuno Chemistry, Spain, Company Share (%), 2011 129
Figure 64: Infectious Immunology, Market Segmentation 131
Figure 65: Infectious Immunology Market, Spain, Revenue Mix ($m), 2011 132
Figure 66: Infectious Immunology Market, Spain, Segment Contribution (%), 2011 133
Figure 67: Infectious Immunology, Spain, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 134
Figure 68: Infectious Immunology, Spain, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 136
Figure 69: Infectious Immunology Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-
Figure 70: Infectious Immunology Rapid Tests, Spain, Revenue ($m) USD Constant, by Sub-
Figure 71: Infectious Immunology, Spain, Company Share (%), 2011 143
Figure 72: Microbiology Culture, Market Segmentation 145
Figure 73: Microbiology Culture Market, Spain, Revenue Mix ($m), 2011 146
Figure 74: Microbiology Culture Market, Spain, Segment Contribution (%), 2011 147
Figure 75: Microbiology Culture, Spain, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 148
Figure 76: Microbiology Culture, Spain, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 150
Figure 77: Microbiology Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 152
Figure 78: Microbiology Analyzers, Spain, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 154
Figure 79: Microbiology Culture, Spain, Company Share (%), 2011 157
Figure 80: Siemens Healthcare, Company Share (%),Spain In Vitro Diagnostics Market, 2011 159
Figure 81: F. Hoffmann-La Roche Ltd., Company Share (%),Spain In Vitro Diagnostics Market,
2011 160
Figure 82: Abbott Laboratories, Company Share (%),Spain In Vitro Diagnostics Market, 2011 161

Figure 83: Beckman Coulter, Inc., Company Share (%),Spain In Vitro Diagnostics Market, 2011
162
Figure 84: bioMerieux S.A., Company Share (%),Spain In Vitro Diagnostics Market, 2011 163
Figure 85: Ortho-Clinical Diagnostics Inc., Company Share (%),Spain In Vitro Diagnostics Market,
2011 164
Contact: sales@reportsandreports.com for more information.

Spain In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (14)

Similar to Spain In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Similar to Spain In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture (20)

Spain In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture